JP2022504760A5 - - Google Patents
Info
- Publication number
- JP2022504760A5 JP2022504760A5 JP2021520113A JP2021520113A JP2022504760A5 JP 2022504760 A5 JP2022504760 A5 JP 2022504760A5 JP 2021520113 A JP2021520113 A JP 2021520113A JP 2021520113 A JP2021520113 A JP 2021520113A JP 2022504760 A5 JP2022504760 A5 JP 2022504760A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- solvate
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024099957A JP2024123152A (ja) | 2018-10-12 | 2024-06-20 | 化学療法難治性がんの治療のための新しい併用薬方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811195239.3 | 2018-10-12 | ||
| CN201811195239 | 2018-10-12 | ||
| PCT/CN2019/110904 WO2020074010A1 (zh) | 2018-10-12 | 2019-10-12 | 治疗化疗难治性癌症的新联合用药方案 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024099957A Division JP2024123152A (ja) | 2018-10-12 | 2024-06-20 | 化学療法難治性がんの治療のための新しい併用薬方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022504760A JP2022504760A (ja) | 2022-01-13 |
| JP2022504760A5 true JP2022504760A5 (https=) | 2022-10-20 |
| JP7513286B2 JP7513286B2 (ja) | 2024-07-09 |
Family
ID=70163618
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021520113A Active JP7513286B2 (ja) | 2018-10-12 | 2019-10-12 | 化学療法難治性がんの治療のための新しい併用薬方法 |
| JP2024099957A Pending JP2024123152A (ja) | 2018-10-12 | 2024-06-20 | 化学療法難治性がんの治療のための新しい併用薬方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024099957A Pending JP2024123152A (ja) | 2018-10-12 | 2024-06-20 | 化学療法難治性がんの治療のための新しい併用薬方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US12257227B2 (https=) |
| EP (1) | EP3865130A4 (https=) |
| JP (2) | JP7513286B2 (https=) |
| CN (2) | CN113164438B (https=) |
| AU (1) | AU2019357933B2 (https=) |
| BR (1) | BR112021006898A2 (https=) |
| CA (1) | CA3115869A1 (https=) |
| EA (1) | EA202190771A1 (https=) |
| IL (1) | IL282228A (https=) |
| MX (1) | MX2021004151A (https=) |
| PH (1) | PH12021550815A1 (https=) |
| SG (1) | SG11202103707TA (https=) |
| TW (1) | TWI848990B (https=) |
| WO (1) | WO2020074010A1 (https=) |
| ZA (1) | ZA202102494B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7513286B2 (ja) * | 2018-10-12 | 2024-07-09 | １グローブ バイオメディカル カンパニー， リミテッド | 化学療法難治性がんの治療のための新しい併用薬方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20160625T1 (hr) | 2007-09-10 | 2016-08-12 | Boston Biomedical, Inc. | Novi inhibitori stat3 signalnog puta i inhibitori matičnih stanica raka |
| WO2011116398A1 (en) | 2010-03-19 | 2011-09-22 | Boston Biomedical, Inc. | Novel compounds and compositions for targeting cancer stem cells |
| ES2987670T3 (es) | 2010-03-19 | 2024-11-15 | 1Globe Biomedical Co Ltd | Métodos novedosos para actuar sobre células madre cancerosas |
| JP2014511384A (ja) | 2011-03-04 | 2014-05-15 | ゾウシャン ハイジョンジョウ シンシェン ファーマシューティカルズ カンパニー リミテッド | 疾患治療のための４，９−ジヒドロキシ−ナフト［２，３−ｂ］フランの新規エステル |
| WO2013166618A1 (en) * | 2012-05-08 | 2013-11-14 | Zhoushan Haizhongzhou Xinsheng Pharmaceuticals Co., Ltd. | PRODRUGS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR CIRCUMVENTING CANCER MULTIDRUG RESISTANCE |
| CA2908380A1 (en) | 2013-04-09 | 2014-10-16 | Boston Biomedical, Inc. | Methods for treating cancer |
| JP2018511643A (ja) | 2015-04-17 | 2018-04-26 | ボストン バイオメディカル， インコーポレイテッド | 癌を治療するための方法 |
| EP3405189A1 (en) | 2016-01-20 | 2018-11-28 | Boston Biomedical, Inc. | Methods for treating cancer |
| CN107766371B (zh) * | 2016-08-19 | 2023-11-17 | 中兴通讯股份有限公司 | 一种文本信息分类方法及其装置 |
| JP7513286B2 (ja) * | 2018-10-12 | 2024-07-09 | １グローブ バイオメディカル カンパニー， リミテッド | 化学療法難治性がんの治療のための新しい併用薬方法 |
-
2019
- 2019-10-12 JP JP2021520113A patent/JP7513286B2/ja active Active
- 2019-10-12 US US17/284,654 patent/US12257227B2/en active Active
- 2019-10-12 AU AU2019357933A patent/AU2019357933B2/en active Active
- 2019-10-12 CA CA3115869A patent/CA3115869A1/en active Pending
- 2019-10-12 BR BR112021006898-8A patent/BR112021006898A2/pt unknown
- 2019-10-12 CN CN201980066957.7A patent/CN113164438B/zh active Active
- 2019-10-12 CN CN202510203958.9A patent/CN120168498A/zh active Pending
- 2019-10-12 WO PCT/CN2019/110904 patent/WO2020074010A1/zh not_active Ceased
- 2019-10-12 SG SG11202103707TA patent/SG11202103707TA/en unknown
- 2019-10-12 MX MX2021004151A patent/MX2021004151A/es unknown
- 2019-10-12 EA EA202190771A patent/EA202190771A1/ru unknown
- 2019-10-12 EP EP19871382.8A patent/EP3865130A4/en active Pending
- 2019-10-14 TW TW108136944A patent/TWI848990B/zh active
-
2021
- 2021-04-11 IL IL282228A patent/IL282228A/en unknown
- 2021-04-12 PH PH12021550815A patent/PH12021550815A1/en unknown
- 2021-04-15 ZA ZA2021/02494A patent/ZA202102494B/en unknown
-
2024
- 2024-06-20 JP JP2024099957A patent/JP2024123152A/ja active Pending
-
2025
- 2025-02-25 US US19/063,086 patent/US20250235425A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022537551A5 (https=) | ||
| RU2012147739A (ru) | Пероральные составы, содержащие аналоги цитидина, и способы их использования | |
| JP2021527092A5 (https=) | ||
| JP2021512121A5 (https=) | ||
| US20120157472A1 (en) | Method for treating colorectal cancer | |
| IL178745A (en) | Use of 4- (amino) -2 (2, 6-dioxo (3-piperidyl)) -isoindoline -1, 3-discussion of preparation of a medical vaccine for the treatment of myeloma | |
| JP2020516646A5 (https=) | ||
| JP2012522837A5 (https=) | ||
| JP2020517696A5 (https=) | ||
| JP2022509262A5 (https=) | ||
| JP2023527542A5 (https=) | ||
| JP2014144962A5 (https=) | ||
| JP2023548055A5 (https=) | ||
| WO2017184086A1 (en) | Method of treating liver cancer | |
| JP2024016209A5 (https=) | ||
| JP2024517085A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| JP2022504760A5 (https=) | ||
| MX2024006270A (es) | Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2023531090A5 (https=) | ||
| JP6895688B2 (ja) | 血液がんの新規治療法及び新規治療剤 | |
| JP7282072B2 (ja) | 肺がんの治療に使用するための組み合わせ | |
| JP2005508323A5 (https=) | ||
| JP2022520859A5 (https=) | ||
| RU2678103C2 (ru) | Противоопухолевое средство, содержащее противоопухолевый комплекс платины, и усилитель противоопухолевого эффекта |